Investment Banking Update: Notable March Transactions and Cautious Optimism Ahead BlogInvestment Banking TeamApril 3, 2023Investment Banking, Capital, Markets, Investing, Biotech, Medtech
The Transactional Landscape Of ADCs: A Payday for Payloads BlogBack Bay Life Science AdvisorsMarch 2, 2023Capital, Biotech, M&A, Oncology, Transactions, Deal Landscape, Small Molecule Therapeutics
Healthcare Companies Venture Back into Public Markets BlogInvestment Banking TeamFebruary 27, 2023Investment Banking, Capital, Markets, Investing, Biotech, Medtech
Proving the Promise of Gene Replacement and Editing in Treatment of Inherited Blood Diseases BlogBack Bay Life Science AdvisorsFebruary 24, 2023Capital, Biotech, Cell therapy, Cell and Gene
Prepare for What the Markets Could Bring BlogInvestment Banking TeamJanuary 18, 2023Investment Banking, Capital, Markets, Investing, Biotech, Medtech
